Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00025935 · ClinicalTrials.gov registry record
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
A clinical trial of Mood Disorder, sponsored by National Institute of Mental Health (NIMH).
- Recruiting
- Registry status
- 2,350
- Enrollment target
- 1
- Study location
NCT00025935: Recruiting study of Mood Disorder, sponsored by National Institute of Mental Health (NIMH).
NCT00025935 is a study of Mood Disorder that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 2,350 participants, above the 972-participant average among 7 other Mood Disorder trials with a reported enrollment target (142% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00025935, a study of Mood Disorder, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).
- RECRUITING
- Registry status
- 2,350 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD) display chronic anger, sadness, or irritability, as well as hyperarousal (such as insomnia, distractibility, hyperactivity) and extreme responses to frustration (such as frequent, severe temper tantrums). Researchers will describe the moods and behaviors of children with these symptoms and use specialized testing and brain imaging to learn about the brain changes associated with this disorder.
Primary Outcome
Individuals with full or subthreshold DMDD and/or MDD, ADHD, anxiety (see protocol 00-M-0192), and healthy volunteers (see protocol 00-M-0198).
Conditions Studied
Interventions
- DRUG Lithium
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,350 participants |
| Start Date | 2002-01-01 |
What NCT00025935 shows while recruiting
NCT00025935 is an observational study that tracks outcomes without assigning an intervention. Its 2,350 participants enrollment target places it among the larger protocols in the corpus, above the 972-participant average among 7 other Mood Disorder trials with a reported enrollment target (142% higher).
The record links to 1 condition, with Mood Disorder appearing as the primary indexed condition, and to 1 intervention - of which Lithium is the first listed.
NCT00025935 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00025935 about?
NCT00025935 is a clinical study titled "Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder". This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD) display chronic anger, sadness, or irritability, as well as hyperarousal (such as insomnia, distractibility, hyperactivi...
What is the current status of trial NCT00025935?
This trial is currently recruiting. The enrollment target is 2,350 participants. The study started on 2002-01-01.
What conditions does trial NCT00025935 study?
This clinical trial studies the following conditions: Mood Disorder.
What interventions are being tested in trial NCT00025935?
The interventions under investigation include: Lithium (DRUG).
Who is sponsoring clinical trial NCT00025935?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00025935 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mood Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Premenstrual Syndrome and Premenstrual Dysphoria
RECRUITING
-
Adolescence, Puberty, and Emotion Regulation
COMPLETED
-
Perimenopause-Related Mood and Behavioral Disorders
COMPLETED
-
Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers
COMPLETED
-
Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
COMPLETED · Phase 2
-
Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03099850 · 2,345 participants
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- NCT05868421 · 2,376 participants · NA
Veteran Social Support for Enhancing Use of Smoking Cessation Treatment
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI